HyperRAB (rabies immune globulin (human)) NDC 13533-318

Product information

Brand name (proprietary)

HyperRAB

Generic name (nonproprietary)

rabies immune globulin (human)

Active ingredients

Human rabies virus immune globulin — 300 [iU]/mL

Dosage form

Injection, Solution

Route

Infiltration, Intramuscular

Labeler

GRIFOLS USA, LLC

Product type

Plasma derivative

Marketing category

BLA — Biologics License ApplicationApplication BLA 101144

Marketing start

Jun 12, 1974

Listing expires

Dec 31, 2026

Identifiers

Product ID 13533-318_880a0273-4487-4f86-a949-2c91898bdd78SPL ID 880a0273-4487-4f86-a949-2c91898bdd78

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N413533031801 followed by a unit qualifier and the quantity Copy

Package 13533-0318-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under BLA 101144

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.